Insider Selling: Mesa Laboratories, Inc. (NASDAQ:MLAB) CFO Sells 642 Shares of Stock

Mesa Laboratories, Inc. (NASDAQ:MLAB - Get Free Report) CFO John Sakys sold 642 shares of the business's stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $97.12, for a total transaction of $62,351.04. Following the completion of the transaction, the chief financial officer now directly owns 12,865 shares of the company's stock, valued at $1,249,448.80. This trade represents a 4.75% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Mesa Laboratories Stock Performance

Mesa Laboratories stock traded up $1.61 during mid-day trading on Wednesday, reaching $94.34. 98,988 shares of the company traded hands, compared to its average volume of 44,965. The firm's fifty day moving average is $111.75 and its two-hundred day moving average is $125.47. The company has a market capitalization of $515.07 million, a price-to-earnings ratio of -254.89 and a beta of 0.88. Mesa Laboratories, Inc. has a fifty-two week low of $83.68 and a fifty-two week high of $155.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.63 and a quick ratio of 0.47.

Mesa Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Friday, May 30th were paid a $0.16 dividend. The ex-dividend date of this dividend was Friday, May 30th. This represents a $0.64 dividend on an annualized basis and a yield of 0.68%. Mesa Laboratories's dividend payout ratio (DPR) is -172.97%.

Institutional Trading of Mesa Laboratories

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MLAB. Vanguard Group Inc. increased its holdings in shares of Mesa Laboratories by 0.5% in the first quarter. Vanguard Group Inc. now owns 384,613 shares of the medical instruments supplier's stock valued at $45,638,000 after purchasing an additional 1,757 shares during the period. Raymond James Financial Inc. boosted its position in Mesa Laboratories by 6.5% in the first quarter. Raymond James Financial Inc. now owns 264,013 shares of the medical instruments supplier's stock valued at $31,328,000 after buying an additional 16,218 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in Mesa Laboratories by 191.8% in the 4th quarter. Ameriprise Financial Inc. now owns 151,862 shares of the medical instruments supplier's stock worth $20,026,000 after buying an additional 99,819 shares during the period. Northern Trust Corp raised its position in Mesa Laboratories by 2.0% during the 4th quarter. Northern Trust Corp now owns 93,789 shares of the medical instruments supplier's stock worth $12,368,000 after buying an additional 1,825 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its stake in Mesa Laboratories by 10.3% during the 4th quarter. Janus Henderson Group PLC now owns 86,286 shares of the medical instruments supplier's stock valued at $11,379,000 after acquiring an additional 8,092 shares during the period. Institutional investors and hedge funds own 90.60% of the company's stock.

Wall Street Analysts Forecast Growth

MLAB has been the topic of a number of analyst reports. Wall Street Zen downgraded Mesa Laboratories from a "strong-buy" rating to a "buy" rating in a report on Friday, May 30th. Wells Fargo & Company cut their price target on shares of Mesa Laboratories from $120.00 to $100.00 and set an "underweight" rating on the stock in a report on Friday, May 30th.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.